Nolok (Loteprednol Etabonate)

Loteprednol etabonate binds to glucocorticoid receptors in ocular tissues, inhibiting phospholipase A2 and reducing the production of prostaglandins and leukotrienes. By suppressing these inflammatory mediators, the drug decreases vascular permeability, edema, and cellular infiltration, leading to reduced swelling and pain in the eye.

The dosing regimen for Nolok is determined by the prescribing ophthalmologist based on the specific indication, severity of inflammation, and patient response. The prescriber will provide detailed instructions on the number of drops, frequency, and duration of therapy tailored to each individual case.

Safety data for loteprednol etabonate in pregnancy and lactation are limited. The decision to use Nolok during pregnancy or while breastfeeding should be made by a qualified healthcare professional after weighing the potential benefits against any possible risks to the mother and child.

To request Nolok, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Loteprednol etabonate is a soft‑steroid designed to provide anti‑inflammatory efficacy similar to traditional corticosteroids while minimizing the risk of intraocular pressure elevation and cataract formation. Compared with stronger steroids such as dexamethasone, Nolok often offers a more favorable safety profile for short‑term use in mild to moderate inflammation.

Nolok should be stored at room temperature, preferably below 25 °C. Keep the bottle in its original packaging, protect it from direct light and moisture, and ensure the cap is tightly closed to maintain sterility and potency throughout its shelf life.

Nolok is applied as an ophthalmic suspension. The patient instills the prescribed number of drops into the affected eye(s) using the provided dropper, typically avoiding contact between the tip and the ocular surface or eyelashes. Hands should be washed before administration, and the recommended dosing interval should be followed precisely.

The most serious risks include a significant rise in intraocular pressure that can lead to glaucoma, development of cataracts with prolonged use, and rare but severe allergic reactions such as swelling, rash, or difficulty breathing. Prompt medical attention is required if any of these symptoms occur.

Nolok is contraindicated in patients with known hypersensitivity to loteprednol etabonate or any component of the formulation. It should also be avoided in individuals with active viral eye infections (e.g., herpes simplex keratitis) and in those for whom corticosteroid therapy is otherwise contraindicated.